398 related articles for article (PubMed ID: 18201950)
21. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease.
Rojo LE; Fernández JA; Maccioni AA; Jimenez JM; Maccioni RB
Arch Med Res; 2008 Jan; 39(1):1-16. PubMed ID: 18067990
[TBL] [Abstract][Full Text] [Related]
22. Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology.
Münch G; Apelt J; Rosemarie-Kientsch-Engel ; Stahl P; Lüth HJ; Schliebs R
J Neurochem; 2003 Jul; 86(2):283-9. PubMed ID: 12871569
[TBL] [Abstract][Full Text] [Related]
23. Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo.
Bai Y; Ma X
Int Immunopharmacol; 2020 Nov; 88():106790. PubMed ID: 32795892
[TBL] [Abstract][Full Text] [Related]
24. Respiratory infection promotes T cell infiltration and amyloid-β deposition in APP/PS1 mice.
McManus RM; Higgins SC; Mills KH; Lynch MA
Neurobiol Aging; 2014 Jan; 35(1):109-21. PubMed ID: 23993702
[TBL] [Abstract][Full Text] [Related]
25. The role of chronic self-propagating glial responses in neurodegeneration: implications for long-lived survivors of human immunodeficiency virus.
Mrak RE; Griffin WS
J Neurovirol; 1997 Aug; 3(4):241-6. PubMed ID: 9291232
[TBL] [Abstract][Full Text] [Related]
26. Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E.
Bales KR; Du Y; Holtzman D; Cordell B; Paul SM
Neurobiol Aging; 2000; 21(3):427-32; discussion 451-3. PubMed ID: 10858588
[No Abstract] [Full Text] [Related]
27. Cell mediators of inflammation in the Alzheimer disease brain.
Akiyama H; Arai T; Kondo H; Tanno E; Haga C; Ikeda K
Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S47-53. PubMed ID: 10850730
[TBL] [Abstract][Full Text] [Related]
28. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.
Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X
J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984
[TBL] [Abstract][Full Text] [Related]
29. Triptolide Rescues Spatial Memory Deficits and Amyloid-β Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.
Cui YQ; Wang Q; Zhang DM; Wang JY; Xiao B; Zheng Y; Wang XM
Curr Alzheimer Res; 2016; 13(3):288-96. PubMed ID: 26906357
[TBL] [Abstract][Full Text] [Related]
30. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP
J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.
Niranjan R
Mol Neurobiol; 2013 Dec; 48(3):412-28. PubMed ID: 23420079
[TBL] [Abstract][Full Text] [Related]
33. Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: neuronal and glial control.
Salmina AB; Inzhutova AI; Malinovskaya NA; Petrova MM
J Alzheimers Dis; 2010; 22(1):17-36. PubMed ID: 20847414
[TBL] [Abstract][Full Text] [Related]
34. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
35. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.
von Bernhardi R; Eugenín J
Antioxid Redox Signal; 2012 May; 16(9):974-1031. PubMed ID: 22122400
[TBL] [Abstract][Full Text] [Related]
37. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
[TBL] [Abstract][Full Text] [Related]
38. Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer's disease pathophysiology.
Cornejo F; Vruwink M; Metz C; Muñoz P; Salgado N; Poblete J; Andrés ME; Eugenín J; von Bernhardi R
Brain Behav Immun; 2018 Mar; 69():336-350. PubMed ID: 29246456
[TBL] [Abstract][Full Text] [Related]
39. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
40. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
